Related Content
Download content relating to this event and topic.
The 4th ANZ Biologics Festival 2026 unites biopharma leaders to advance Australia & New Zealand's biologics industry through innovation partnerships and manufacturing expansion.
Excellence in Biologics Manufacturing, Cell and Gene Therapy, and RNA Therapeutics for Australia & New Zealand's Future Biologics Industry.
With a biotechnology sector benchmarked for global excellence due to world-class facilities, researchers, and regulation, the ANZ region has a promising future for biologics innovation and manufacturing. The path ahead will require a focus on further commercial translation of research, and as such, partnerships and collaborations will be critical. Expanding sovereign manufacturing in Australia & New Zealand will also play a massive role in uplifting the sector in the region.
The 4th annual ANZ Biologics Festival 2026 is the region's premier conference that aims to gather the innovators, pioneers, and leaders in the biologics fraternity, including Biologics, Biosimilars, Vaccines, Cell and Gene Therapy (CGT), and RNA Therapeutics, to showcase the latest from ideation to commercialization phase and beyond. It provides the right environment to meet the entire biopharma fraternity under one roof.
Join us to bring investment to Australia & New Zealand's bio sector and explore a wealth of opportunities in biologics innovation, expanding the region's manufacturing footprint, and advancing cell and gene therapy and RNA therapeutics. The 2026 festival will feature dedicated tracks on Biologics Manufacturing, Cell and Gene Therapy, and RNA Therapeutics, offering a comprehensive view of the latest advancements and challenges in these critical areas.
View the Key Themes for
ANZ Biologics Festival 2026
Register today to secure your ticket.
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.
Dr Lauren Giorgio is currently the Chief Operating Officer at GPN Vaccines, a biotech company developing vaccines for the world’s most important bacterial pathogens. She has spent her career working alongside world-leading academics and clinicians to commercialise medical research, including at the Centre for Eye Research Australia and the Walter and Eliza Hall Institute. Lauren has a PhD in molecular biology from the University of Adelaide and is a Graduate from the Australian Institute of Company Directors.
Ahsan, a prominent figure in the pharmaceutical industry, holds esteemed positions as the Director of Quality and CMC Regulatory at QBiotics, Director CMC and Quality at Neurala Biosciences and the Managing Director of Aphex Pharma Solutions. Renowned for his expertise in driving product development and ensuring quality with commercial viability, Ahsan has left an indelible mark on the industry. His leadership roles are complemented by a versatile skill set encompassing CMC development, regulatory and GxP compliance, quality improvement, risk management, and process validation. Ahsan's impactful contributions extend beyond his professional roles. He has presented in seminars across prominent cities such as Melbourne, Sydney, Brisbane, Auckland, and Singapore, showcasing his thought leadership and expertise to diverse audiences. Ahsan's career trajectory includes significant positions at Leo Pharma, Hospira Australia Ltd., QBiotics and various other esteemed organisations, where he consistently contributed to product development and quality management. Ahsan's unwavering dedication to excellence and his ability to drive positive change have solidified his reputation as a trusted leader in the pharmaceutical sector.
Dr Airey is Chief Medical Officer at Cynata and a senior biopharmaceutical executive with extensive global experience in drug development and commercialization. A physician by training, she has played key roles in advancing novel biologics and other pharmaceutical products from early research through to global market approval. Her expertise spans clinical trial design and execution across multiple phases, therapeutic areas, and geographies. Before joining Cynata in 2021, Dr Airey was Director of Translational Development at CSL Limited. Her earlier career includes a range of medical leadership roles in biotech, pharmaceutical, and clinical research organizations, contributing to the successful approval of multiple pharmaceutical and biologic products.
Tim Oldham PhD is CEO and Managing Director of AdAlta Ltd, whose “East to West” cellular immunotherapy strategy is seeking to make innovation in China CAR-T cell therapy available to western patients via Australia. He has more than 20 years experience in biopharmaceutical development, manufacturing and commercialisation, including more than 10 years cell and gene therapy experience gained in business development, strategic marketing and regional leadership roles at Mayne Pharma’s Europe, Middle East and Africa unit, as President APAC for Hospira and CEO of Cell Therapies Pty Ltd prior to his role at AdAlta Ltd.
Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.
Choose a plan that fits your role, company, and industry.
Early Bird Rate : SGD 1,495
(Valid until 5th September 2025)
Registration Open Rate : SGD 1,695
(Valid until 7th November 2025)
Standard Rate : SGD 1,895
(Valid until 9th January 2025)
Final Call Rate : SGD 2,095
(Valid until 4th February 2025)
Applicable to company profiles (headquartered within the APAC region):
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations
Early Bird Rate : SGD 1,995
(Valid until 5th September 2025)
Registration Open Rate : SGD 2,195
(Valid until 7th November 2025)
Standard Rate : SGD 2,395
(Valid until 9th January 2025)
Final Call Rate : SGD 2,595
(Valid until 4th February 2025)
Applicable to company profiles (headquartered outside of the APAC region):
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations
Early Bird Rate : SGD 2,995
(Valid until 5th September 2025)
Registration Open Rate : SGD 3,195
(Valid until 7th November 2025)
Standard Rate : SGD 3,395
(Valid until 9th January 2025)
Final Call Rate : SGD 3,595
(Valid until 4th February 2025)
Applicable to company profiles:
Job Profiles: Business Development, Marketing, and Sales
Be the first in line! Register your interest now to get exclusive access to Super Early-Bird tickets - the lowest prices available - before they go live.
Contact the IMAPAC to learn about our sponsorship process, rates and more.
Visit the event page to view more content.
Download content relating to this event and topic.
Visit the event page to view more content.
Visit the awards page to view more content.
To stay informed about event updates, including date, venue, and agenda, please subscribe to our newsletter on our event website. You can also follow our official social media channels for real-time updates and announcements.
The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.
We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.
Yes, we have a cancellation and refund policy in place. Please refer to our “Cancellation Policy” on our website for details on how to request a refund if you are unable to attend.
We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines.
Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.
Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals
Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.
Yes, we offer sponsorship and exhibition opportunities for businesses and organizations. Please visit our this page on our website for more information.
To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines.
Don't miss out on unique networking, speaking and sponsorship opportunities.